Metabolic immaturity and breastmilk bile acid metabolites are central determinants of heightened newborn vulnerability to norovirus diarrhea
Amy Peiper, Joyce Morales Aparicio, Zhengzheng Hu, Lufuno Phophi, Emily W. Helm, Rebecca Rubinstein, Matthew B. Phillips, Caroline G. Williams, Saravanan Subramanian, Michael Cross, Neha Iyer, Quyen Nguyen, Rachel C. Newsome, Christian Jobin, Stephanie N. Langel, Filemón Bucardo, Sylvia Becker‐Dreps, Xiao‐Di Tan, Paul A. Dawson, Stephanie M. Karst
Abstract
The pathogenic outcome of enteric virus infections is governed by a complex interplay between the virus, intestinal microbiota, and host immune factors, with metabolites serving as a key mediator. Noroviruses bind bile acid metabolites, which are produced by the host and then modified by commensal bacteria. Paradoxically, bile acids can have both proviral and antiviral roles during norovirus infections. Working in an infant mouse model of norovirus infection, we demonstrate that microbiota and their bile acid metabolites protect from norovirus diarrhea, whereas host bile acids promote disease. We also find that maternal bile acid metabolism determines the susceptibility of newborn mice to norovirus diarrhea during breastfeeding. Finally, targeting maternal and neonatal bile acid metabolism can protect newborn mice from norovirus disease. In summary, neonatal metabolic immaturity and breastmilk bile acids are central determinants of heightened newborn vulnerability to norovirus disease.